Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nifedipine 30 mg SR tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nifedipine 30 mg SR Tablet is a long-acting calcium channel blocker (CCB) used to manage high blood pressure and angina pectoris. Nifedipine works by blocking the influx of calcium ions into the smooth muscle cells of the heart and blood vessels, causing vasodilation, improved oxygen delivery, and reduced cardiac workload. The sustained-release (SR) formulation provides a controlled, gradual release of the medication over 24 hours, ensuring stable blood pressure control and reduced risk of sudden hypotension compared to immediate-release forms. Nifedipine 30 mg SR is commonly prescribed as part of long-term therapy for essential hypertension, chronic stable angina, and vasospastic (Prinzmetal’s) angina. Its once-daily dosing improves patient compliance while maintaining consistent therapeutic effects.
Common side effects include headache, flushing, dizziness, ankle swelling (peripheral edema), palpitations, and fatigue. Some patients may experience mild gastrointestinal disturbances such as nausea or constipation. Rare adverse effects include hypotension, gingival hyperplasia (gum overgrowth), or reflex tachycardia. Most side effects are mild and may resolve as the body adjusts to the medication or after dose adjustment.
Nifedipine 30 mg SR Tablet is indicated for the treatment of essential hypertension and the management of chronic stable angina and vasospastic angina. It may also be used in resistant hypertension in combination with other antihypertensive agents.
Nifedipine 30 mg SR Tablet should be taken strictly as prescribed. Do not chew, split, or crush the sustained-release tablet, as this can lead to rapid drug release and increased side effects. It is contraindicated in patients with severe aortic stenosis, cardiogenic shock, or hypersensitivity to Nifedipine. Caution is advised in patients with heart failure, severe hypotension, or liver impairment. Abrupt discontinuation should be avoided as it can worsen angina or cause a rebound rise in blood pressure. Grapefruit juice should be avoided during therapy as it can increase Nifedipine levels in the blood. The medication is not recommended during pregnancy unless clearly indicated and should be used cautiously during breastfeeding under medical supervision.
Store Nifedipine 30 mg SR Tablet in a cool, dry place below 30°C. Protect it from moisture, heat, and direct sunlight. Keep the medication out of reach of children and pets. Do not use after the expiry date printed on the packaging.
Composition : Aceclofenac (200mg) Tablet
Composition : Aceclofenac (200mg) + Pregabalin (75mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Chlorzoxazone (250mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Cetirizine (10mg) + Phenylephrine (5mg) + Caffeine (25mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) Tablet
Composition : Acetylcysteine (600mg) effervescent
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nifedipine 30 mg SR Tablet is a sustained-release calcium channel blocker used for the management of hypertension (high blood pressure), chronic stable angina, and other cardiovascular conditions. It works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart. The sustained-release formulation provides prolonged therapeutic action and enhances patient compliance. This product is widely prescribed in the cardiology and cardiovascular care segment, making it a valuable opportunity for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and healthcare institutions. As hypertension and heart-related disorders require long-term treatment, Nifedipine 30 mg SR Tablet generates regular prescriptions, repeat purchases, and stable market demand, supporting sustainable business growth.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiology and cardiovascular care segment with monopoly rights, quality-assured manufacturing standards, attractive promotional support, and reliable product availability for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription volume, long-term patient adherence, increasing cardiovascular healthcare needs, and continuous demand from hospitals and clinics, making this product a profitable and dependable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiology and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiovascular care segment.